Gan and Lee Pharmaceuticals, USA   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Beijing China (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2015
NCT02506647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Gan and Lee Pharmaceuticals, USA | Gan & Lee Pharmaceuticals, USA | Gan & Lee Pharmaceuticals USA Corporation